苇茎汤联合常规西药治疗小儿迁延性细菌性支气管炎临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R725.6

基金项目:


Clinical Study on Weijing Decoction Combined with Routine Western Medicine for Persistent Bacterial Bronchitis in Children
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察苇茎汤联合西药对症支持治疗小儿迁延性细菌性支气管炎(PBB) 的临床疗效。方 法:选取85 例PBB 患儿为研究对象,按随机数字表法分为对照组42 例和观察组43 例。对照组给予常规西药 治疗,观察组在对照组基础上给予苇茎汤口服。比较2 组临床疗效、中医证候评分、肺功能、炎症因子及T 淋巴细胞亚群变化。结果:观察组总有效率为90.70%,高于对照组73.81%(P<0.05)。治疗后,2 组咳嗽多 痰、咳痰黄稠、舌红苔黄等评分较治疗前降低(P<0.05),且观察组各项中医证候评分低于对照组(P< 0.05)。治疗后,2 组肺活量(FVC)、第1 秒用力呼气容积(FEV1)、呼吸峰流速(PEF) 较治疗前升高(P< 0.05),且观察组FVC、FEV1、PEF 高于对照组(P<0.05)。治疗后,2 组白细胞介素-6 (IL-6)、白细胞介 素-4(IL-4)、C-反应蛋白(CRP) 水平较治疗前降低(P<0.05),且观察组IL-6、IL-4、CRP 水平均低于对 照组(P<0.05)。治疗后,2 组CD3+、CD4+水平较治疗前升高,CD8+水平较治疗前降低(P<0.05);且观察组 CD3+、CD4+水平高于对照组,CD8+低于对照组(P<0.05)。结论:苇茎汤联合西药对症支持治疗小儿PBB 的 临床效果佳,可显著改善患儿临床症状,提升肺部通气功能,减轻炎症反应,提高免疫力。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Weijing Decoction combined with western medicine on persistent bacterial bronchitis (PBB) in children. Methods:A total of 85 children with PBB were selected as the study objects,and divided into the control group and the observation group according to the random number table method , with 42 and 43 cases in each group respectively. The control group was given routine western medicine, and the observation group was treated with oral administration of Weijing Decoction based on the treatment of the control group. The changes of clinical effects,traditional Chinese medicine (TCM) syndrome scores,lung function,inflammatory factors and T lymphocyte subsets were compared between the two groups. Results:The total effective rate was 90.70% in the observation group,higher than that of 73.81% in the control group (P<0.05). After treatment,the scores of cough and excessive phlegm, coughing of yellow and thick phlegm, and red tongue and yellow coating in the two groups were decreased when compared with those before treatment (P<0.05),and the above three TCM syndrome scores in the observation group were lower than those in the control group (P<0.05). After treatment, the forced vital capacity (FVC), forced expiratory volume in one second (FEV1) and peak expiratory flow (PEF) in both groups were increased when compared with those before treatment (P< 0.05),and the FVC,FEV1 and PEF in the observation group were higher than those in the control group (P< 0.05). After treatment,the levels of interleukin-6 (IL-6),interleukin-4 (IL-4) and C-reactive protein (CRP) in both groups were decreased when compared with those before treatment (P<0.05), and the above three levels in the observation group were lower than those in the control group (P<0.05). After treatment, the levels of CD3 + and CD4 + in the two groups were increased when compared with those before treatment, and the levels of CD8 + were decreased (P<0.05); the levels of CD3 + and CD4 + in the observation group were higher than those in the control group,and the CD8+ level was lower than that in the control group (P<0.05). Conclusion:Weijing Decoction combined with western medicine has a sound clinical effect on PBB in children, which can significantly improve the clinical symptoms of children, enhance the pulmonary ventilation function, mitigate the inflammatory responses and increase the immunity.

    参考文献
    相似文献
    引证文献
引用本文

李杰.苇茎汤联合常规西药治疗小儿迁延性细菌性支气管炎临床研究[J].新中医,2023,55(7):62-65

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-04-12
  • 出版日期:
文章二维码